BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11719862)

  • 1. [Renovascular hypertension: angioplasty need not be essential].
    Philipp T
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1349-50. PubMed ID: 11719862
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients.
    Ravogli A; Arzilli F; Omboni S; Giovannetti R; Mutti E; Salvetti A; Mancia G
    J Hypertens; 1996 Jan; 14(1):53-6. PubMed ID: 12013495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical profiles of 78 patients with renovascular hypertension].
    Kudo K; Abe K; Yasujima M; Seino M; Sato M; Omata K; Hiwatari M; Kanazawa M; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1989 Apr; 78(4):493-9. PubMed ID: 2526191
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pathogenesis and treatment of renovascular hypertension].
    Kusano E; Akai Y
    Nihon Rinsho; 1989 Sep; 47(9):2008-12. PubMed ID: 2574241
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present status of secondary hypertension therapy].
    Miyamori I
    Nihon Naika Gakkai Zasshi; 1990 Jan; 79(1):76-80. PubMed ID: 2139092
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical and non-medical approaches to renovascular hypertension.
    Spitalewitz S; Weber MA; Reiser IW
    Cardiologia; 1997 Mar; 42(3):237-43. PubMed ID: 9141238
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renovascular hypertension].
    Sugita A
    Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):641-9. PubMed ID: 2526891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
    Jonker GJ; Huisman RM; de Zeeuw D
    Nephrol Dial Transplant; 1993; 8(9):798-807. PubMed ID: 8255511
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
    Palmer BF
    Nephrol Dial Transplant; 2003 Oct; 18(10):1973-5. PubMed ID: 13679467
    [No Abstract]   [Full Text] [Related]  

  • 12. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
    Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
    Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational decision making in the treatment of renal artery stenosis.
    Mitterbauer C; Oberbauer R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):1-3. PubMed ID: 12407927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angioplasty of renal artery stenosis in patients with renal failure and renovascular hypertension].
    RowiƄski O
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():13-4; discussion 14-5. PubMed ID: 12621775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renovascular hypertension. Stents are in great demand despite the scantiness of relevant data].
    Aumiller J
    MMW Fortschr Med; 2007 Mar; 149(11):43-4. PubMed ID: 20104701
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need yet another blocker of the renin-angiotensin system?
    Messerli FH; Re RN
    J Am Coll Cardiol; 2007 Mar; 49(11):1164-5. PubMed ID: 17367659
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renovascular hypertension: is it only the top of the iceberg?].
    Lewandowski J
    Pol Merkur Lekarski; 2003 Oct; 15(88):371-5; discussion 375-6. PubMed ID: 14974369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.